Major Interests in Shares

RNS Number : 2961Q

Alliance Pharma PLC

30 July 2010

 



For immediate release

30 July 2010

Alliance Pharma plc

TR-1: Notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Alliance Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	On market transfer between indirect and direct funds			Yes
3. Full name of person(s) subject to the notification obligation: iii		Aviva plc & its subsidiaries
4. Full name of shareholder(s)  (if different from 3.):iv		Registered Holder: BNY Norwich Union Nominees Limited           1,494,754*                                                               Chase (GA Group) Nominees Limited              9,622,074* CUIM Nominee Limited                                   2,356,377* *denotes direct interest BNP Paribas - London                                    1,846,572 Chase Nominees Limited                                6,144,127 State Street Nominees Limited                        2,352,851
5. Date of the transaction and date on which the threshold is crossed or reached: v		29 July 2010
6. Date on which issuer notified:		30 July 2010
7. Threshold(s) that is/are crossed or reached: vi, vii		4% to 5% Change at Direct Interest Level

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction				Resulting situation after the triggering transaction
	Number of Shares		Number of Voting Rights		Number of shares	Number of voting rights			% of  voting rights x
					Direct	Direct xi		Indirect xii	Direct		Indirect
Ordinary Shares GB0031030819	23,316,755		23,316,755		23,816,755	13,473,205		10,343,550	5.79%		4.45%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Expiration date xiii		Exercise/ Conversion Period xiv			Number of voting rights that may be acquired if the instrument is exercised/ converted.			% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date xvii	Exercise/ Conversion period xviii	Number of voting rights instrument refers to	% of voting rights xix, xx
					Nominal	Delta
Total (A+B+C)
Number of voting rights				Percentage of voting rights
23,816,755				10.24%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: ·      Aviva plc (Parent Company) ·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) ·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
10. Name of the proxy holder:		See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Figures are based on the total number of voting rights of  232,533,372.
14. Contact name:	Diane Thirkettle
15. Contact telephone number:	01603 687803

 

END

 

 

HOLLLFIEDTIIVII